<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901732</url>
  </required_header>
  <id_info>
    <org_study_id>603EUSA03</org_study_id>
    <nct_id>NCT00901732</nct_id>
  </id_info>
  <brief_title>Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer</brief_title>
  <official_title>Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jazz Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jazz Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who have been diagnosed with a head and/or neck cancer commonly develop oral
      mucositis (OM). The purpose of this study is to estimate the effect of Caphosol on OM and to
      evaluate if Caphosol had any effect on clinical outcomes which include quality of life, oral
      intake, swallowing function and pain.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective is to estimate ht incidence of OM in H&amp;N cancer patients undergoing radiation therapy with or without chemotherapy and/or sensitizer who receive Caphosol.</measure>
    <time_frame>15 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary objective of this study is to correlate components of OM data with clinical outcomes (pain, narcotic use, oral intake)</measure>
    <time_frame>15 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oral Mucositis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Caphosol</intervention_name>
    <description>Oral Mouth Rinse</description>
    <other_name>supersaturated solution of calcium and phosphate ions.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed Head and Neck Cancer patients with planned Radiation therapy

          -  Have at least one of 10 pre-defined anatomic mucosal subsites on view

          -  Age &gt;/= 18 years

          -  Life expectancy &gt;/= 6 months

          -  Planned RT to the head/neck

          -  Must be able to perform oral rinse

        Exclusion Criteria:

          -  Active infections of oral cavity

          -  physiologic condition that precludes the use of an oral rinse

          -  Hypersensitivity to Caphosol ingredients

          -  Presence of mucosal ulceration at baseline

          -  Poorly controlled hypertension, DM or other serious medical/psychiatric illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andy M Trotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center, Tampa Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David M Brizel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Duke University, Durham, North Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David I Rosenthal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD Anderson Cancer Center, Houston, Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Chambers, MD</last_name>
    <role>Study Director</role>
    <affiliation>MD Anderson Cancer Center, Houston, Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Curtis T Miyamoto, MD</last_name>
    <role>Study Director</role>
    <affiliation>Temple University Hospital, Philadelphia, PA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Hu, MD</last_name>
    <role>Study Director</role>
    <affiliation>Beth Israel Medical Center, New York, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Amdur, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Florida, Gainesville, Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Manyak, MD</last_name>
    <phone>609-750-8200</phone>
    <email>michael.manyak@eusapharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Colleen Gramkowski, MST</last_name>
    <phone>609-750-8219</phone>
    <email>colleen.gramkowski@eusapharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Florida College of Medicine</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Amdur, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Bridgett Fitzgerald</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andy Trotti, MD</last_name>
      <phone>813-745-8424</phone>
    </contact>
    <contact_backup>
      <last_name>Margaret Lotrimare</last_name>
      <phone>813-745-7223</phone>
      <email>margaret.lomartire@moffitt.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Hu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Brizel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Curtis T Miyamoto, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jennifer Curry, RN</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Chambers, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2009</study_first_submitted>
  <study_first_submitted_qc>May 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2009</study_first_posted>
  <last_update_submitted>May 13, 2009</last_update_submitted>
  <last_update_submitted_qc>May 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>Michael Manyak, MD / Medical Monitor</name_title>
    <organization>EUSA Pharma (USA), INc</organization>
  </responsible_party>
  <keyword>Caphosol</keyword>
  <keyword>Oral Mucositis</keyword>
  <keyword>Eusa Pharma</keyword>
  <keyword>Moffitt Cancer Center</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

